Apolipoprotein C-II deficiency: identification of a structural variant ApoC-II Padova. 1988

S S Fojo, and G Baggio, and C Gabelli, and K Higuchi, and M Bojanovski, and R E Gregg, and H B Brewer
Molecular Disease Branch, National Heart, Lung and Blood Institute, Bethesda, MD 20892.

Apolipoprotein(apo) C-II DNA, RNA and protein from a patient with a familial deficiency of apoC-II were evaluated and compared to normal individuals. No major defect of the apoC-II gene could be detected by Southern blot hybridization. Northern and slot blot analyses of total liver RNA documented normal levels of a normal sized apoC-II mRNA. Immunohistochemical studies of the liver of the apoC-II deficient patient revealed a normal to slightly elevated intracellular content of the C-II apolipoprotein. Plasma apoC-II was 3 to 5% of normal apoC-II levels and exhibited abnormal electrophoretic mobility on two dimensional gel electrophoresis and immunoblotting. We postulate that at the molecular level, the deficiency of apoC-II in the plasma of this patient results from a structural defect in the coding portion of the apoC-II gene leading to either defective secretion of cellular apoC-II or increased catabolism of a structurally defective apoC-II in plasma.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001056 Apolipoproteins C A group of apolipoproteins that can readily exchange among the various classes of lipoproteins (HDL; VLDL; CHYLOMICRONS). After lipolysis of TRIGLYCERIDES on VLDL and chylomicrons, Apo-C proteins are normally transferred to HDL. The subtypes can modulate remnant binding to receptors, LECITHIN CHOLESTEROL ACYLTRANSFERASE, or LIPOPROTEIN LIPASE. Apo-C,Apo C,ApoC,Apoprotein (C),Apoproteins C
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic
D053304 Apolipoprotein C-II A 9-kDa protein component of VERY-LOW-DENSITY LIPOPROTEINS. It contains a cofactor for LIPOPROTEIN LIPASE and activates several triacylglycerol lipases. The association of Apo C-II with plasma CHYLOMICRONS; VLDL, and HIGH-DENSITY LIPOPROTEINS is reversible and changes rapidly as a function of triglyceride metabolism. Clinically, Apo C-II deficiency is similar to lipoprotein lipase deficiency (HYPERLIPOPROTEINEMIA TYPE I) and is therefore called hyperlipoproteinemia type IB. Apo C-II,ApoC2,Apolipoprotein C-2,Apolipoprotein CII,Apoprotein C-II,Apo C II,Apolipoprotein C 2,Apolipoprotein C II,Apoprotein C II

Related Publications

S S Fojo, and G Baggio, and C Gabelli, and K Higuchi, and M Bojanovski, and R E Gregg, and H B Brewer
March 1988, Journal of lipid research,
S S Fojo, and G Baggio, and C Gabelli, and K Higuchi, and M Bojanovski, and R E Gregg, and H B Brewer
December 1988, The Journal of biological chemistry,
S S Fojo, and G Baggio, and C Gabelli, and K Higuchi, and M Bojanovski, and R E Gregg, and H B Brewer
December 1989, The Journal of biological chemistry,
S S Fojo, and G Baggio, and C Gabelli, and K Higuchi, and M Bojanovski, and R E Gregg, and H B Brewer
September 1985, Journal of lipid research,
S S Fojo, and G Baggio, and C Gabelli, and K Higuchi, and M Bojanovski, and R E Gregg, and H B Brewer
August 1994, Journal of lipid research,
S S Fojo, and G Baggio, and C Gabelli, and K Higuchi, and M Bojanovski, and R E Gregg, and H B Brewer
February 2016, The Journal of pharmacology and experimental therapeutics,
S S Fojo, and G Baggio, and C Gabelli, and K Higuchi, and M Bojanovski, and R E Gregg, and H B Brewer
August 1981, Metabolism: clinical and experimental,
S S Fojo, and G Baggio, and C Gabelli, and K Higuchi, and M Bojanovski, and R E Gregg, and H B Brewer
January 1986, Advances in experimental medicine and biology,
S S Fojo, and G Baggio, and C Gabelli, and K Higuchi, and M Bojanovski, and R E Gregg, and H B Brewer
January 1998, Ryoikibetsu shokogun shirizu,
S S Fojo, and G Baggio, and C Gabelli, and K Higuchi, and M Bojanovski, and R E Gregg, and H B Brewer
December 1994, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!